Cargando…
High expression of tissue O-linked glycans is associated with a malignant phenotype of cholangiocarcinoma
OBJECTIVE: This study aimed to investigate the expression of O-linked glycoprotein glycans in tissue of patients with cholangiocarcinoma compared with adjacent normal tissue. METHODS: Sixty patients with cholangiocarcinoma were included in the study. Permethylated O-linked glycans from intrahepatic...
Autores principales: | Talabnin, Krajang, Talabnin, Chutima, Khiaowichit, Juthamas, Sutatum, Nuchanard, Asavaritikrai, Pundit, Suksaweang, Sanong, Tongtawee, Taweesak, Ishihara, Mayumi, Azadi, Parastoo, Sripa, Banchob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869157/ https://www.ncbi.nlm.nih.gov/pubmed/33535865 http://dx.doi.org/10.1177/0300060520976864 |
Ejemplares similares
-
Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020) -
Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2018) -
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
por: Khiaowichit, Juthamas, et al.
Publicado: (2022) -
RNF43 overexpression attenuates the Wnt/β-catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
por: Pangestu, Norma Sainstika, et al.
Publicado: (2021) -
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway
por: Chueakwon, Piyasiri, et al.
Publicado: (2022)